NEW YORK, Nov. 22, 2016 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) and Imedex will present a record number of research abstracts at the 2016 Crohn's & Colitis Foundation of America's Advances in Inflammatory Bowel Diseases Clinical and Research Conference (AIBD). AIBD is taking place in Orlando, Florida on December 8-10, 2016. "The field of inflammatory bowel disease is moving faster than ever before, as evidenced in both quantity and quality of research being presented at this year's conference. There are over eighty presentations in both the clinical and basic science sessions, with innovative findings and important outcomes across the board," said Richard P. MacDermott, MD, Emeritus Professor of Medicine, Albany Medical Center, conference co-chair. Attendees will gain insight into current research via clinical presentations, including epidemiology and outcomes research revealing important research results including longitudinal study results from the Ocean State Crohn's and Colitis Area Study (OSCCAR),encouraging clinical trials data, and significant findings in pediatric complications and diagnostics. "We are also seeing innovative translational studies and basic science research presentations addressing the microbiome and the dietary impact on the human gut microbiota," continued MacDermott. At AIBD, clinicians will gain immediately-implementable, practice-changing knowledge, while researchers will be immersed in the latest results in the rapidly changing scientific landscape. For the first time ever, the conference's nursing agenda, which empowers nurses and allied healthcare providers to develop best practices in interprofessional IBD patient care, will be certified by the American Academy of CME, Inc, an accredited provider of continuing nursing education. More than 60 expert specialists from the U.S. and abroad from institutions including Harvard Medical School, Northwestern Feinberg School of Medicine, Icahn School of Medicine at Mount Sinai, Cedars Sinai, and Mayo Clinic will lead sessions, including 15 new faculty added this year. Approximately 2,400 participants are expected to attend this year's conference, which is endorsed by the American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), the Latin American Society for Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN) and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). The conference will be organized and certified for AMA PRA Category 1 Credits™ by Imedex, a global leader in education, and for ANCC (American Nurses Credentialing Center's Commission on Accreditation) contact hours by American Academy of CME, Inc. For more information or to register, visit http://www.advancesinibd.com. About the Crohn's & Colitis Foundation of AmericaThe Crohn's & Colitis Foundation of America (CCFA) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). CCFA's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those afflicted with IBD. For more information visit www.ccfa.org, call 888-694-8872, or email firstname.lastname@example.org. About ImedexImedex is the industry leader in developing and delivering independent, accredited health care education. Our programs, specializing in gastroenterology, oncology, and hematology, are provided through live events around the world, as well as effective online educational opportunities for on-the-go healthcare providers. With high-quality scientific programming translating the latest research into clinically-relevant information, our activities address the needs of healthcare professionals inundated by information through exceptional organization and outstanding educational value, with a proven sustained impact on patient care.